Peripheral-type benzodiazepine-binding sites in platelets of schizophrenics with and without tardive dyskinesia

Ronit Weizman, Zehava Tanne, Leon Karp, Sam Tyano, Moshe Gavish*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

The density of peripheral-type benzodiazepine (BZ)-binding sites was studied in platelets of 10 medicated chronic schizophrenics with tardive dyskinesia (TD), 10 medicated chronic schizophrenics without TD, 7 drug-free schizophrenics, and 10 normal controls. The age range of the study population was 36-60 years. Age and sex distribution were similar in all 4 groups. The unmedicated schizophrenics did not differ in their maximal binding capacity from the healthy controls. A significant decrease in the density of peripheral-type BZ-binding sites in platelets was observed in treated schizophrenics both with and without TD in comparison to controls and untreated schizophrenics. The reduction in [3H]PK 11195 binding was more pronounced in TD patients (31.3% of controls) than in patients without TD (21.1% of controls). However, this parameter failed to discriminate statistically between TD and non-TD medicated schizophrenics.

Original languageEnglish
Pages (from-to)549-555
Number of pages7
JournalLife Sciences
Volume39
Issue number6
DOIs
StatePublished - 11 Aug 1986

Funding

FundersFunder number
Charles E. Smith Family Foundation
Fund for Basic Research
Israel Institute for Psychobiology
Israel Academy of Sciences and Humanities
Ministry of Health, State of Israel

    Fingerprint

    Dive into the research topics of 'Peripheral-type benzodiazepine-binding sites in platelets of schizophrenics with and without tardive dyskinesia'. Together they form a unique fingerprint.

    Cite this